Literature DB >> 12796539

The clinical features of 16 cases of stroke associated with administration of IVIg.

James B Caress1, Michael S Cartwright, Peter D Donofrio, James E Peacock.   

Abstract

This report characterizes the clinical features of 16 cases of stroke associated with IV immunoglobulin infusions. Fourteen of the strokes occurred within 24 hours of an infusion and 50% of the patients were receiving IV immunoglobulin for the first time. Nine patients had multifocal infarctions. All but one of the patients had stroke risk factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796539     DOI: 10.1212/01.wnl.0000068335.01620.9d

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

1.  New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins.

Authors:  Martin Stangel
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

Review 2.  Intravenous immunoglobulin: adverse effects and safe administration.

Authors:  Hedi Orbach; Uriel Katz; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

3.  Intravenous immunoglobulin-related thromboembolic events - an accusation that proves the opposite.

Authors:  M Basta
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 4.  Pemphigus.

Authors:  Michael Kasperkiewicz; Christoph T Ellebrecht; Hayato Takahashi; Jun Yamagami; Detlef Zillikens; Aimee S Payne; Masayuki Amagai
Journal:  Nat Rev Dis Primers       Date:  2017-05-11       Impact factor: 52.329

Review 5.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

6.  Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study.

Authors:  Chad Heatwole; Nicholas Johnson; Robert Holloway; Katia Noyes
Journal:  J Clin Neuromuscul Dis       Date:  2011-12

7.  Management of myocardial infarction in immune thrombocytopenic purpura with anti-phospholipid antibodies.

Authors:  Rie Tabata; Chiharu Tabata; Yoshio Kita
Journal:  J Thromb Thrombolysis       Date:  2013-01       Impact factor: 2.300

Review 8.  Initial and long-term management of autoimmune neuropathies.

Authors:  Carol Lee Koski
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 9.  Intravenous immunoglobulin therapy in rheumatic diseases.

Authors:  Jagadeesh Bayry; Vir Singh Negi; Srini V Kaveri
Journal:  Nat Rev Rheumatol       Date:  2011-05-10       Impact factor: 20.543

10.  Thromboembolic complications of intravenous immunoglobulin (IVIG) in an immunocompromised patient with Chronic Lymphocytic Leukemia: a case report.

Authors:  Cannon Milani; Samir M Dalia; Gerald A Colvin
Journal:  Cases J       Date:  2009-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.